1. Home
  2. ARAY vs RNXT Comparison

ARAY vs RNXT Comparison

Compare ARAY & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$0.28

Market Cap

39.3M

Sector

Health Care

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.91

Market Cap

37.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARAY
RNXT
Founded
1990
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.3M
37.0M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
ARAY
RNXT
Price
$0.28
$0.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$3.50
$8.25
AVG Volume (30 Days)
1.8M
212.7K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
87.50
20.00
EPS
N/A
N/A
Revenue
N/A
$1,123,000.00
Revenue This Year
N/A
$194.66
Revenue Next Year
$4.58
$279.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$0.24
$0.70
52 Week High
$2.10
$1.45

Technical Indicators

Market Signals
Indicator
ARAY
RNXT
Relative Strength Index (RSI) 47.93 47.96
Support Level $0.28 $0.87
Resistance Level $0.36 $0.98
Average True Range (ATR) 0.03 0.05
MACD 0.00 -0.00
Stochastic Oscillator 47.37 15.42

Price Performance

Historical Comparison
ARAY
RNXT

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: